Capital International Inc’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$109M Sell
299,765
-98,304
-25% -$33.7M 0.76% 32
2026
Q1
$140M Sell
398,069
-27,444
-6% -$9.78M 1.08% 23
2025
Q4
$139M Buy
425,513
+38,729
+10% +$12.3M 1.1% 19
2025
Q3
$109M Buy
386,784
+71,908
+23% +$20.9M 0.87% 29
2025
Q2
$87.9M Buy
314,876
+85,551
+37% +$24.2M 0.85% 25
2025
Q1
$71.4M Buy
229,325
+62,061
+37% +$18.3M 0.87% 26
2024
Q4
$43.6M Buy
167,264
+57,347
+52% +$17M 0.51% 53
2024
Q3
$35.4M Buy
109,917
+1,153
+1% +$377K 0.45% 64
2024
Q2
$34M Buy
108,764
+8,523
+9% +$2.5M 0.45% 62
2024
Q1
$28.5M Buy
+100,241
New +$29.3M 0.38% 76
2022
Q1
Sell
-5,420
Closed -$1.22M 296
2021
Q4
$1.22M Hold
5,420
0.01% 275
2021
Q3
$1.15M Buy
+5,420
New +$1.25M 0.01% 275

Other funds holding AMGN

Capital International Inc's AMGN Position: Q2 2026 in Review

Capital International Inc reduced its Amgen (AMGN) stake by 25% in Q2 2026, selling an estimated $33.7M and leaving 299,765 shares worth $109M. The position accounts for 0.76% of the portfolio, ranked #32.

Capital International Inc first reported a position in AMGN in Q3 2021 and has held it in 12 quarters since. The position peaked at $140M in Q1 2026. 3,153 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Capital International Inc held 299,765 shares of Amgen worth $109M as of Q2 2026.
  • Capital International Inc sold 98,304 Amgen shares in Q2 2026, an estimated $33.7M.
  • Amgen made up 0.76% of Capital International Inc's portfolio in Q2 2026, its #32 holding.
  • Capital International Inc first reported a position in Amgen in Q3 2021 and has held it in 12 quarters since.
  • Capital International Inc's Amgen position peaked at $140M in Q1 2026.
  • 3,153 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Capital International Inc's 13F filing for Q2 2026, filed 12 Aug 2026.